Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Meisel

Showing results (251-260 of 311) with videos related to

Pageof 32
Sort By:
Plos One|May 15, 2008
Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trialHendrik Harms, Konstantin Prass, Christian Meisel, et al.
Trials|February 5, 2014
Physical fitness training in Subacute Stroke (PHYS-STROKE)--study protocol for a randomised controlled trialAgnes Flöel, Cordula Werner, Ulrike Grittner, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 19, 2024
Robotic-assisted extended thymectomy for large resectable thymoma: 21 years' experienceLuyu Huang, Zhongmin Li, Feng Li, et al.
BMJ (Clinical Research Ed.)|September 20, 2019
Physical Fitness Training in Patients with Subacute Stroke (PHYS-STROKE): multicentre, randomised controlled, endpoint blinded trialAlexander H Nave, Torsten Rackoll, Ulrike Grittner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2012
Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic statePhilipp Mergenthaler, Anja Kahl, Anne Kamitz, et al.
Acta Neuropathologica Communications|April 22, 2026
Complement deposition, IgG subtyping and endplate destruction in LRP4-ab-positive myasthenia gravisSarah Hoffmann, Katharina Brokamp, Andreas Meisel, et al.
Patient Education and Counseling|March 20, 2026
Patient-oriented navigation in stroke and lung cancer patients: Results on feasibility and efficacy of two randomized controlled trials in GermanyKathrin Gödde, Alice Schneider, Raphael Kohl, et al.
European Journal of Immunology|March 30, 2026
Selective Depletion of Autoreactive Plasma Cells as a Novel Strategy to Treat Acetylcholine Receptor Antibody-Positive Myasthenia GravisLaleh Khodadadi, Deborah Puppe, Dilara S Cirillo, et al.
Annals of Clinical and Translational Neurology|April 14, 2025
ADAPT NXT: Fixed Cycles or Every-Other-Week IV Efgartigimod in Generalized Myasthenia GravisAli A Habib, Kristl G Claeys, Vera Bril, et al.
European Stroke Journal|April 23, 2019
Clinical risk scores for predicting stroke-associated pneumonia: A systematic reviewAmit K Kishore, Andy Vail, Benjamin D Bray, et al.
Pageof 32

Showing results (251-260 of 311) with videos related to

Sort By:
Pageof 32
Plos One|May 15, 2008
Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trialHendrik Harms, Konstantin Prass, Christian Meisel, et al.
Trials|February 5, 2014
Physical fitness training in Subacute Stroke (PHYS-STROKE)--study protocol for a randomised controlled trialAgnes Flöel, Cordula Werner, Ulrike Grittner, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 19, 2024
Robotic-assisted extended thymectomy for large resectable thymoma: 21 years' experienceLuyu Huang, Zhongmin Li, Feng Li, et al.
BMJ (Clinical Research Ed.)|September 20, 2019
Physical Fitness Training in Patients with Subacute Stroke (PHYS-STROKE): multicentre, randomised controlled, endpoint blinded trialAlexander H Nave, Torsten Rackoll, Ulrike Grittner, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2012
Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic statePhilipp Mergenthaler, Anja Kahl, Anne Kamitz, et al.
Acta Neuropathologica Communications|April 22, 2026
Complement deposition, IgG subtyping and endplate destruction in LRP4-ab-positive myasthenia gravisSarah Hoffmann, Katharina Brokamp, Andreas Meisel, et al.
Patient Education and Counseling|March 20, 2026
Patient-oriented navigation in stroke and lung cancer patients: Results on feasibility and efficacy of two randomized controlled trials in GermanyKathrin Gödde, Alice Schneider, Raphael Kohl, et al.
European Journal of Immunology|March 30, 2026
Selective Depletion of Autoreactive Plasma Cells as a Novel Strategy to Treat Acetylcholine Receptor Antibody-Positive Myasthenia GravisLaleh Khodadadi, Deborah Puppe, Dilara S Cirillo, et al.
Annals of Clinical and Translational Neurology|April 14, 2025
ADAPT NXT: Fixed Cycles or Every-Other-Week IV Efgartigimod in Generalized Myasthenia GravisAli A Habib, Kristl G Claeys, Vera Bril, et al.
European Stroke Journal|April 23, 2019
Clinical risk scores for predicting stroke-associated pneumonia: A systematic reviewAmit K Kishore, Andy Vail, Benjamin D Bray, et al.
Pageof 32